The U.S. Food and Drug Administration's Center for Tobacco Products (CTP) has released two new resources to assist applicants in preparing and submitting revised pre-market tobacco product applications (PMTAs).
Explanation - Revision Note: Completion of FDA Form 4057a", "Video - Utilizing CTP Portal Website
The disclosure document provides a quick guide for filling out the FDA 4057a form for revising pre-market tobacco product applications and submitting general correspondence.
In most cases, the CTP can only review PMTA revisions that include the FDA 4057a form. When submitting a PMTA revision, the FDA will first review the required FDA 4057a form. If necessary information is missing from the form, the FDA may not continue with the review of the revision.
The video provides an overview of the CTP portal website and how to use it, including how to search for and track application submission numbers online.
References:
Newly Available Tools to Aid in PMTA Amendment Submission.
The video of the FDA tobacco compliance webinar.
Amendment Tips: How to fill out Form FDA 4057a.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
